Skip to main content
. 2020 Mar 19;2020:6017105. doi: 10.1155/2020/6017105

Table 1.

Comparisons of the means of studied variables between obese and nonobese hypertensive and control subjects at baseline (fasting state).

Variables at fasting state Nonobese patients mean ± S.E (n = 9) Obese patients mean ± S.E (n = 11) t-test P value Nonobese control mean ± S.E (n = 7) Obese control mean ± S.E (n = 8) t-test P value
Systolic BP (mmHg) 150.7 ± 4.2 151.8 ± 4.4 0.85 119.1 ± 5.1 119.8 ± 2.2 0.92
Diastolic BP (mmHg) 98.1 ± 3.3 100.8 ± 5.6 0.68 80.0 ± 3.0 79.6 ± 1.6 0.92
Mean BP (mmHg) 115.7 ± 3.4 117.9 ± 5.1 0.72 93.0 ± 3.6 93.1 ± 1.8 0.98
Plasma glucose (mg/dL) 80.6 ± 3.2 82.0 ± 3.6 0.77 85.4 ± 5.9 93.0 ± 4.7 0.34
Serum Na+(mmol/L) 135.0 ± 1.8 138.2 ± .9 0.17 139.4 ± 1.6 141.0 ± 1.4 0.47
Serum K+ (mmol/L) 3.8 ± 0.1 3.9 ± 0.1 0.63 3.9 ± 0.1 4.1 ± .1 0.18
Serum insulin (μIU/ml) 14.6 ± 2.8 15.5 ± 2.0 0.80 8.9 ± 0.7 9.4 ± 1.3 0.70
Serum aldosterone (pg/ml) 205.9 ± 20.1 191.7 ± 14.5 0.566 126.6 ± 12.6 167.6 ± 10.4 0.02
Serum angiotensin II (ng/ml) 31.7 ± 0.48 35.2 ± 2.1 0.153